Loading…

Reliable Pain Relief But Variable Return to Play After Arthroscopic Elbow Debridement in Baseball Players

We sought to determine the rate of return to play (RTP) in baseball players following arthroscopic elbow debridement for the management of the symptomatic elbow. A retrospective case series with prospectively collected data via questionnaire was conducted on all baseball players who underwent an art...

Full description

Saved in:
Bibliographic Details
Published in:Arthroscopy, Sports Medicine, and Rehabilitation Sports Medicine, and Rehabilitation, 2021-10, Vol.3 (5), p.e1295-e1299
Main Authors: Stenson, James F., Cheesman, Quincy T., Kirsch, Jacob M., Antonacci, Christopher L., Alberta, Frank G., Austin, Luke S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We sought to determine the rate of return to play (RTP) in baseball players following arthroscopic elbow debridement for the management of the symptomatic elbow. A retrospective case series with prospectively collected data via questionnaire was conducted on all baseball players who underwent an arthroscopic elbow debridement, from July, 15, 2004 to November 1, 2017. A postoperative questionnaire was released at an average 7.25 year follow-up. Data collected included age, gender, laterality, preoperative diagnosis, range of motion, duration and characterization of symptoms, visual analog scale (VAS) pain score, complications, level of play, and RTP. Follow-up data were available on 18 baseball players. Average age was 19.7 years (range 16-24). Seventeen were pitchers, and 1 was a catcher. Level of play included 12 collegiate athletes, 2 high school athletes, 2 recreational athletes, 1 minor league athletes, and 1 major league athlete. Rate of RTP was 61% (11/18) with 6 returning to a greater level and 5 to an equal level. The length of time to RTP following surgery was most commonly within 6-8 months (44.4%, 8/18). Mean VAS pain score improved from 6.9 to 0.75 (P =
ISSN:2666-061X
2666-061X
DOI:10.1016/j.asmr.2021.05.010